Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled colistin for ventilator-associated pulmonary infection caused by multidrug-resistant Acinetobacter
IRCT2017091236068N1Phase 3Completed
- Sponsor
- Research Council of Iran University of Medical Sciences
- Start
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of colistin in ventilator-associated pneumonia (VAP) and Acinetobacter infection, sponsored by Research Council of Iran University of Medical Sciences. Started Mar 2016; status: completed.
02
Drugs
colistin
03
Conditions
ventilator-associated pneumonia (VAP)Acinetobacter infection
Beyond the preview
Go deeper on IRCT2017091236068N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017091236068N1.